Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lycovary Daily is an oral dietary supplement and nutraceutical product developed by Lycotec and launched by Cambridge Diagnostic Imaging for women's health indications. It is a proprietary lycosome-formulated combination containing docosahexaenoic acid, lutein, and zeaxanthin, designed to improve ovarian tissue oxygenation and cellular respiration rather than acting through a conventional single defined pharmaceutical receptor target. Based on the provided context, it has been positioned for symptoms associated with premenstrual syndrome, dysmenorrhea, and menopause including hot flushes and night sweats, with claimed enhanced bioavailability versus conventional omega-3 products through its specialized formulation technology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lycovary Daily.